6 Analysts Have This To Say About Corcept Therapeutics
6 Analysts Have This To Say About Corcept Therapeutics
6位分析師對corcept醫療發表看法
During the last three months, 6 analysts shared their evaluations of Corcept Therapeutics (NASDAQ:CORT), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，有6位分析師分享了他們對Corcept Therapeutics（納斯達克：CORT）的評價，展現出看好和看淡各異的前景。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.67, a high estimate of $65.00, and a low estimate of $38.00. Surpassing the previous average price target of $45.80, the current average has increased by 6.27%.
12個月的分析師價格目標揭示了一些分析師的見解，呈現出平均目標價格爲48.67美元，最高估價爲65.00美元，最低估價爲38.00美元。當前的平均目標價格已經超過了先前的平均目標價格45.80美元，增加了6.27%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探討分析師評級：分析師評級的深度探討
The analysis of recent analyst actions sheds light on the...
最近分析師行動的分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。